Clinical Trials on Non-small Cell Carcinoma in Argentina
Total 284 results
-
Laboratorio Elea Phoenix S.A.CompletedAdvanced Non-small Cell Lung CancerArgentina
-
Laboratorio Elea Phoenix S.A.Syneos HealthRecruitingNon Small Cell Lung Cancer MetastaticArgentina
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Brazil, Chile, Mexico
-
Hoffmann-La RocheCompletedCarcinoma, Non-small-cell LungArgentina
-
Mast Therapeutics, Inc.Worldwide Clinical Trials; Synteract, Inc.; Thywill Latam Solutions SRL; OCASA...CompletedA Bioequivalence Study of Vinorelbine Tartrate Injectable Emulsion in Patients With Advanced Cancer.Breast Cancer | Non-small Cell Lung Cancer | Non-Hodgkins LymphomaArgentina
-
Eli Lilly and CompanyCompletedNon-small Cell Lung CancerUnited States, Argentina, China, Korea, Republic of
-
AbbVieRecruitingNon Small Cell Lung CancerCanada, United Kingdom, Argentina, Japan, Switzerland
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CarcinomaBelgium, France, Germany, Portugal, Spain, Sweden, Italy, United States, Canada, Netherlands, Argentina, Australia, Austria, Brazil, Denmark, Finland, Greece, Hungary, India, Israel, Korea, Republic of, Mexico, Poland, Puerto Rico, Taiwan, Turk... and more
-
AstraZenecaCompletedNon-small-cell Lung Cancer (NSCLC)Mexico, Peru, Argentina, Taiwan, India, Thailand, Colombia, Uruguay, Chile, Dominican Republic
-
Bristol-Myers SquibbCompletedNon Small Cell Lung CancerKorea, Republic of, Taiwan, United States, Spain, France, Argentina, Canada, Poland
-
Bristol-Myers SquibbEli Lilly and Company; Clovis Oncology, Inc.; ExelixisWithdrawnCarcinoma, Non-small Cell Lung CancerNetherlands, Norway, Belgium, Greece, United States, Argentina, Denmark, Mexico, Poland, Romania
-
R-PharmCompletedAdvanced/Metastatic Non-Small Cell Lung CancerGermany, Korea, Republic of, Russian Federation, Taiwan, Australia, Italy, France, United States, Argentina, Spain
-
Eli Lilly and CompanyCompletedNon-Small-Cell Lung CarcinomaArgentina, Israel, United States, Spain, Germany, Belgium, Italy, Brazil, France, Canada, Netherlands, Turkey
-
AstraZenecaCompletedNon-small Cell Lung CancerVietnam, Turkey, Philippines, Thailand, Egypt, Singapore, India, Peru, Argentina, Chile, Colombia, Costa Rica, Dominican Republic, Kuwait, Mexico
-
AstraZenecaApproved for marketingNon Small Cell Lung Cancer (NSCLC)Taiwan, Thailand, Turkey, Brazil, Philippines, Russian Federation, Romania, Austria, Hungary, Bulgaria, Latvia, India, Argentina, Australia, Estonia, Malaysia, Mexico, Singapore, South Africa
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, United Kingdom, Latvia, Italy, Israel, Argentina, Germany
-
TelikCompletedStudy of TLK286 (Telcyta) vs. Gefitinib in Locally Advanced or Metastatic Non-Small Cell Lung CancerNon Small Cell Lung CarcinomaUnited States, Australia, Brazil, Chile, Germany, Argentina, Italy, United Kingdom
-
AstraZenecaRecruitingCarcinoma | Non-Small-Cell LungChina, Israel, Spain, United States, Canada, Italy, Korea, Republic of, Belgium, Bulgaria, Vietnam, Japan, United Kingdom, Brazil, France, Philippines, Taiwan, Thailand, Germany, Poland, Austria, Greece, Turkey, Malaysia, Argentina, Hong... and more
-
Hoffmann-La RocheActive, not recruitingNon-small Cell Lung CancerCanada, Brazil, Korea, Republic of, Spain, Argentina, United States, Costa Rica, Chile, Latvia, Finland, Italy, Poland
-
AstraZenecaActive, not recruitingNon Small Cell Lung Carcinoma NSCLCDenmark, United Kingdom, United States, Poland, Brazil, India, Japan, Mexico, Peru, Russian Federation, Turkey, China, Malaysia, Hong Kong, Korea, Republic of, Chile, Israel, Ukraine, Portugal, Greece, Bulgaria, Philippines, Sweden, A... and more
-
Bristol-Myers SquibbCompletedNon-Squamous Cell Non-small Cell Lung CancerUnited States, Germany, Hong Kong, Spain, Australia, Mexico, Austria, France, Singapore, Switzerland, Canada, Poland, Argentina, Brazil, Chile, Czechia, Hungary, Italy, Norway, Peru, Romania, Russian Federation
-
AstraZenecaCompletedNon-Small-Cell Lung CarcinomaUnited States, Croatia, Sweden, Italy, Mexico, Spain, Turkey, Germany, Philippines, Malaysia, China, Estonia, Latvia, Hong Kong, Argentina, Belgium, Canada, Denmark, France, Indonesia, Thailand, Brazil, Switzerland, Singapore, Slovenia
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerUnited States, Argentina, India, Taiwan, Thailand, Vietnam
-
NCIC Clinical Trials GroupCompletedLung CancerCanada, Singapore, Australia, Romania, Argentina, Brazil
-
Genzyme, a Sanofi CompanyCompletedNon-Small-Cell Lung CarcinomaUnited States, France, Italy, Korea, Republic of, Peru, Spain, United Kingdom, Philippines, China, Germany, Hong Kong, Argentina, Austria, Canada, Israel, Taiwan, Mexico, Thailand, Belgium, Australia, Singapore, Netherlands
-
Spectrum Pharmaceuticals, IncCompletedNon-small Cell Lung CancerUnited States, Czechia, India, Brazil, Argentina, Hungary
-
Recombio SLEurofarma Laboratorios S.A.; Laboratorio Elea Phoenix S.A.; Innogene Kalbiotech... and other collaboratorsUnknownNSCLC | Lung Cancer, Non-small CellBrazil, Indonesia, Argentina, Cuba, Philippines, Singapore, Thailand
-
Genentech, Inc.CompletedNon-Squamous Non-Small Cell Lung CancerSpain, France, United States, Taiwan, United Kingdom, Philippines, Latvia, Italy, Israel, Argentina, Mexico, Germany, Malaysia
-
Dizal PharmaceuticalsRecruitingNon-small Cell Lung CancerChina, United States, Argentina, Australia, Austria, Belgium, Brazil, Canada, Czechia, France, Germany, Italy, Netherlands, Poland, Spain, Turkey
-
Novartis PharmaceuticalsTerminatedNon-Small-Cell LungGermany, Spain, Belgium, Canada, Netherlands, Italy, Taiwan, Argentina, Australia, Israel, Japan, Lebanon, France, Poland, United States, Jordan, Korea, Republic of, China, Brazil, Czechia, Greece, Russian Federation, Denmark, Hungary, ... and more
-
BayerCompletedCarcinoma | Non-Small-Cell LungItaly, Spain, China, Korea, Republic of, Bulgaria, Turkey, Greece, Philippines, Taiwan, Russian Federation, Hungary, Singapore, France, Netherlands, Sweden, Belgium, United States, Austria, Thailand, Germany, Israel, Poland, Canada, United... and more
-
Bristol-Myers SquibbCompletedSquamous Cell Non-small Cell Lung CancerUnited States, France, Chile, Australia, Netherlands, Argentina, Austria, Canada, Czechia, Germany, Hungary, Ireland, Italy, Mexico, Norway, Peru, Poland, Romania, Russian Federation, Spain, United Kingdom
-
Merck Sharp & Dohme LLCModernaTX, Inc.RecruitingNon-small Cell Lung CancerPoland, United States, New Zealand, Australia, Costa Rica, Taiwan, Argentina, France, Chile, Hungary, Spain, Greece, Canada, Lithuania, Norway, Italy, Czechia, Estonia, Portugal
-
Hoffmann-La RocheRecruitingNon-small Cell Lung Cancer (NSCLC)Korea, Republic of, United States, China, Japan, Australia, Taiwan, Brazil, Argentina, Hong Kong
-
Hoffmann-La RocheCompletedNon-Squamous Non-Small Cell Lung CancerUnited States, Italy, Canada, Austria, Finland, France, Greece, Korea, Republic of, Panama, Portugal, Spain, Turkey, United Kingdom, Taiwan, Brazil, Germany, Poland, Chile, Guatemala, Russian Federation, Switzerland, Thailand, Ukraine, Serb... and more
-
Bristol-Myers SquibbActive, not recruitingNon-small Cell Lung Cancer | Recurrent Non-small Cell Lung Cancer | Metastatic Non-small Cell Lung CancerAustralia, Russian Federation, United States, Argentina, Austria, Belgium, Brazil, Chile, France, Germany, Italy, Mexico, Poland, Romania, Spain, Switzerland, United Kingdom, Ireland, Netherlands
-
Novartis PharmaceuticalsNo longer availableNon-small Cell Lung Cancer (NSCLC)United States, Argentina, Korea, Republic of, Hong Kong, Thailand, Mexico, Jordan, Colombia, India, Philippines
-
Eli Lilly and CompanyCompletedNon Small Cell Lung CancerIndia, Turkey, China, United States, Germany, Spain, Taiwan, Belgium, Korea, Republic of, France, Greece, Netherlands, United Kingdom, Australia, Canada, Brazil, Ireland, Portugal, Argentina
-
Daiichi Sankyo, Inc.ArQule, Inc. (a wholly owned subsidiary of Merck Sharp and Dohme, a subsidiary...TerminatedNon Squamous, Non-small-cell Lung CancerPoland, France, Germany, Italy, Spain, Canada, United States, Argentina, Belgium, Mexico, Australia, Russian Federation, Netherlands, Peru, Brazil, Austria, United Kingdom, Sweden, Czechia, Chile, Denmark, Hungary, Romania
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyTerminatedNon-small Cell Lung CancerUnited States, Taiwan, Korea, Republic of, Netherlands, Spain, Belgium, Brazil, Japan, China, Australia, Germany, Argentina, Canada, Czechia, France
-
Merck KGaA, Darmstadt, GermanyCompletedNon Small Cell Lung Cancer (NSCLC)Sweden, Australia, Brazil, Bulgaria, Czech Republic, France, Italy, Korea, Republic of, Mexico, Russian Federation, Spain, Turkey, United Kingdom, Germany, Poland, Ukraine, Argentina, Austria, Hungary, Netherlands, Slovakia, Taiwan, Chil... and more
-
Novartis PharmaceuticalsCompletedNon-small Cell Lung CancerFrance, Italy, United Kingdom, Hungary, Belgium, Canada, Spain, Germany, Singapore, Netherlands, Thailand, United States, Turkey, Argentina, Brazil, Hong Kong, Japan, Taiwan
-
AbbVieCompletedNon-squamous Non-small Cell Lung CancerUnited States, Argentina, Australia, Canada, Czechia, Denmark, Finland, Germany, Hungary, Israel, Japan, Korea, Republic of, Netherlands, New Zealand, Russian Federation, South Africa, Spain, Taiwan, Turkey, United Kingdom
-
Genzyme, a Sanofi CompanyCompletedLung Cancer | Non Small Cell Lung CancerUnited States, Australia, France, Italy, South Africa, Spain, United Kingdom, Sweden, Philippines, Germany, Hong Kong, Argentina, Israel, Portugal, Greece, Taiwan, Mexico, Belgium, Venezuela, Colombia, India
-
AstraZenecaCompletedDiagnosis and Treatment Strategies in Patients With NSCLC With or Without EGFR Mutations. (IDENTIFY)Non-Small Cell Lung Cancer | Stage IIIB/IVArgentina
-
Merck Sharp & Dohme LLCActive, not recruitingNon-small Cell Lung CancerUnited States, Argentina, Australia, Belgium, Brazil, Canada, China, Estonia, France, Germany, Ireland, Italy, Japan, Korea, Republic of, Latvia, Lithuania, Malaysia, Poland, Romania, Russian Federation, South Africa, Spain, Taiwan, U... and more
-
AstraZenecaActive, not recruitingNon Small Cell Lung Cancer (Stage III)United States, Spain, Taiwan, Thailand, Vietnam, Turkey, Korea, Republic of, Brazil, Hungary, India, Japan, Mexico, Peru, Russian Federation, China, Malaysia, Argentina
-
Genzyme, a Sanofi CompanyCompletedNon Small Cell Lung CancerUnited States, Australia, Brazil, France, Italy, Korea, Republic of, Mexico, Spain, United Kingdom, Philippines, China, Germany, Norway, Canada, Hong Kong, Argentina, Netherlands, Taiwan, India, Thailand, Indonesia, Denmark
-
Bristol-Myers SquibbOno Pharmaceutical Co. LtdActive, not recruitingNon Small Cell Lung CancerUnited States, China, Hungary, Brazil, Argentina, Canada, France, Greece, Italy, Japan, Korea, Republic of, Romania, Spain, Taiwan, Turkey
-
Bristol-Myers SquibbWithdrawnNon-Small Cell Lung CancerArgentina, Peru, Germany, United States, Canada